Prevention and control of hypertension: Developing a global agenda

Current Opinion in Cardiology

Volumn 29, Issue 4, 2014, Pages 324-330

  Campbell, Norm R C ^a   Niebylski, Mark L ^b  

^a LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^b World Hypertension League   (Canada)

Author keywords

Blood pressure; Chronic noncommunicable diseases; Health promotion; Hypertension; Public health

Indexed keywords

BLOOD PRESSURE MONITORING; COMMUNITY LIVING; DECISION SUPPORT SYSTEM; DISEASE CONTROL; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HUMAN; HYPERTENSION; MEDICAL INFORMATION SYSTEM; MEDICAL SOCIETY; PATIENT CARE; POPULATION RESEARCH; PREVENTION AND CONTROL; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; SELF CARE; SKILL; SOCIAL ENVIRONMENT; ECONOMICS; HEALTH; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH PROMOTION; MORTALITY; PUBLIC-PRIVATE PARTNERSHIP;

DELIVERY OF HEALTH CARE; GLOBAL HEALTH; HEALTH CARE COSTS; HEALTH PLAN IMPLEMENTATION; HEALTH POLICY; HEALTH PRIORITIES; HEALTH PROMOTION; HUMANS; HYPERTENSION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS;

EID: 84904767974     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0000000000000067     Document Type: Review

References (40)

1. Lim SS, Vos T, Flaxman AD, Danaei G, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2013;380:2224-2260. This is a critical analysis of the leading risks for death and disability in 2010.
2. Gaziano TA, Bitton A, Anand S, Weinstein MC. The global cost of nonoptimal blood pressure. J Hypertens 2009;27:1472-1477.
3. World Health Organization. A global brief on hypertension: silent killer, global public health crisis. World Health Day 2013. Report, 1-39. Geneva, Switzerland: World Health Organization; 2013. This book provides key facts on hypertension and needed actions for prevention and control from the World Health Organizations perspective.
4. Udani S, Lazich I, Bakris GL. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol 2011;7:11-21.
5. Levi MN, Macquin-Mavier I, Tropeano AI, et al. Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens 2013;1073-1082.
6. Chen G, McAlister FA, Walker RL, et al. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension 2011;57:891-897.
7. Magee LA, Helewa ME, Moutquin J-M, von Dadelszen P. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008;30:S1-S48.
8. Global Risk Network of the World Economic Forum. Global Risks 2009 - A Global Risk Network Report. World Economic Forum, 3-34. 2009. Cologny/Geneva, Switzerland, World Economic Forum.
9. United Nations General Assembly. Note by the Secretary-General transmitting the report of the Director-General of the World Health Organization on the prevention and control of noncommunicable diseases. Report, 1-19. New York, USA: Department for General Assembly and Conference Management; 2013. Nations and actions and target to prevent noncommunicable disease. Several of the targets relate to hypertension.
10. Campbell N, Young ER, Drouin D, et al. A Framework for discussion on how to improve prevention, management and control of hypertension in Canada. Can J Cardiol 2012;28:262-269.
11. Lackland DT. An international working party on assessing hypertension control in populations: a proposal. J Hum Hypertens 1996;10:S29-S31.
12. Gurven M, Blackwell AD, Rodriguez DE, et al. Does blood pressure inevitably rise with age?: longitudinal evidence among forager- horticulturalists. Hypertension 2012;60:25-33.
13. Committee on Public Health Priorities to Reduce and Control Hypertension in the U. S. Population, Institute of Medicine of the National Academies. A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. Report, v-173. Washington, DC: USA, National Academies Press; 2010.
14. Hooper L, Bartlett C, Smith G D, Ebrahim S. Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ 2002;325:628-637.
15. World Health Organization. Interventions on diet and physical activity: what works: summary report. WHO; 2009;1-48.
16. Elmer PJ, Obarzanek E, Vollmer WM, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control:18-month results of a randomized trial. Ann Intern Med 2006;144:485-495.
17. Plourde G, Prud'homme D. Managing obesity in adults in primary care. CMAJ 2012;184:1039-1044.
18. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension. clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002;288:1882-1888.
19. World Health Organization: Creating an enabling environment for populationbased salt reduction strategies. Report of a joint technical meeting held by WHO and the Food Standards Agency, United Kingdom, July 2010 2011, 1:3-42.
20. World Health Organization. 2008-2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. Report, 01-42. Geneva, Switzerland: WHO Press, World Health Organization; 2008.
21. World Health Organization. Global strategy on diet, physical activity and health: a framework to monitor and evaluate implementation. Report, I-40. Geneva, Switzerland: WHO Press, World Health Organization; 2008.
22. World Health Organization. WHO-global strategy on diet, physical activity and health. Report, 1-18. Geneva, Switzerland: Marketing and Dissemination, World Health Organization; 2004.
23. Joffres M, Campbell NRC, Manns B, Tu K. Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related healthcare costs in Canada. Can J Cardiol 2007;23:437-443.
24. Cook NR, Cohen J, Hebert P, et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med 1995;155:701-709.
25. World Health Organization. Report of the Formal Meeting of Member States to conclude the work on the comprehensive global monitoring framework, including indicators, and a set of voluntary global targets for the prevention and control of noncommunicable diseases. Report, 1-6. Geneva, Switzerland: World Health Organization; 2012.
26. World Health Organization. WHO guideline: sodium intake for adults and children. Report, i-46. Geneva, Switzerland: WHO Press; 2012.
27. World Health Organization. A framework for implementing the set of recommendations on the marketing of foods and nonalcoholic beverages to children. Report, 1-62. Geneva, Switzerland: WHO Press; 2012.
28. World Health Organization, in collaboration with the World Heart Federation and the World Stroke Organization. Global Atlas on cardiovascular disease prevention and control. Edited by Mendis S, Puska P, Norrving B. Report, III-155. Geneva, Switzerland: WHO Press, World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization; 2011
29. World Health Organization. WHO - a prioritized research agenda for prevention and control of noncommunicable diseases. Geneva, Switzerland: WHO; 2010;1-23.
30. Mozheyko M, Eregin S, Vigdorchik A, et al. Changes in hypertension treatment in the yaroslavl region of Russia: improvements observed between 2 crosssectional surveys. J Clin Hypertens (Greenwich) 2013;15:918-924. A demonstration project to increase control of hypertension in a Russian community.
31. Ordunez-Garcia P, Munoz JLB, Pedraza D, et al. Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens 2006;24:845-849.
32. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: World Health Organization; 2003.
33. Campbell NR, McAlister FA, Quan H. Monitoring and evaluating efforts to control hypertension in Canada: why, how, and what it tells us needs to be done about current care gaps. Can J Cardiol 2013;29:564-570. An outline of hypertension surveillance methods with analyses of interventions recommended for identified care gaps.
34. World Health Organization. WHO Global status report on noncommunicable diseases 2010. Report, iii-161. Geneva, Switzerland: WHO Press, World Health Organization; 2011.
35. Falaschetti E, Chaudhury M, Mindell J, Poulter N. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009;53:480-486.
36. Lee H, Park Y, Kwon H, et al. Prevalence, awareness, treatment, and control of hypertension among people over 40 years old in a rural area of South Korea: The Chungju Metabolic Disease Cohort (CMC) Study. Clin Exp Hypertens 2010;32:166-178.
37. Nissinen A, Kastarinen M, Tuomilehto J. Community control of hypertension-experiences from Finland. J Hum Hypertens 2004;18:553-556.
38. Alderman MH. Does blood pressure control require a Cuban-style revolution? J Hypertens 2006;24:811-812.
39. Campbell N, Lackland D, Chockalingam A, et al. The World Hypertension League and International Society of Hypertension call on governments, nongovernmental organizations, and the food industry to work to reduce dietary sodium. J Clin Hypertens (Greenwich) 2014;99-100. This is a policy statement on dietary sodium from the World Hypertension League and the International Society of Hypertension.
40. Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004;22:11-19.